Premium
Letter: biochemical response to combination anti‐retroviral therapy in patients with primary biliary cirrhosis
Author(s) -
Mason A. L.,
MontanoLoza A. J.,
Saxinger L.
Publication year - 2014
Publication title -
alimentary pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.308
H-Index - 177
eISSN - 1365-2036
pISSN - 0269-2813
DOI - 10.1111/apt.12575
Subject(s) - medicine , ursodeoxycholic acid , primary biliary cirrhosis , obeticholic acid , gastroenterology , lamivudine , placebo , regimen , clinical endpoint , immunology , clinical trial , agonist , receptor , pathology , virus , hepatitis b virus , alternative medicine
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom